Healthcare Global Enterprises Ratios

Healthcare Global Enterprises Ltd Ratios

The Healthcare Global Enterprises Ltd Ratios page provides a complete fundamental analysis of Healthcare Global Enterprises Ltd using key valuation, profitability, and financial strength metrics. Investors tracking Healthcare Global Enterprises Ltd Ratios closely monitor D/E, EV, EV/EBITDA, P/B, P/CF, P/E, P/S, and ROE% to evaluate the company's financial performance and valuation trends over time.

Healthcare Global Enterprises Ltd (NSE: HCG, BSE: 539787) is currently trading at ₹525.20, with a market capitalization of ₹78.34B. As a major player in the Health services sector and Hospital/Nursing management industry, Healthcare Global Enterprises Ltd remains a key stock for fundamental analysis using Healthcare Global Enterprises Ltd Ratios.

Healthcare Global Enterprises Ltd Ratios: Valuation Overview

Price to Earnings Ratio (P/E)

The Healthcare Global Enterprises Ltd P/E ratio currently stands at 171.42, making it one of the most tracked metrics in Healthcare Global Enterprises Ltd Ratios.

Historically, the Healthcare Global Enterprises Ltd P/E ratio has shown strong fluctuations:

• 2024: 171.42
• 2023: 98.61
• 2022: 125.05
• 2021: 67.90
• 2020: 0

The rising Healthcare Global Enterprises Ltd P/E ratio indicates increasing investor confidence and premium valuation.

Price to Book Ratio (P/B)

The Healthcare Global Enterprises Ltd P/B ratio reflects how the market values the company's net assets. Current P/B ratio is 8.13.

Historical P/B trend:

• 2024: 8.13
• 2023: 5.70
• 2022: 4.25
• 2021: 4.31

Healthcare Global Enterprises Ltd is trading at a premium to its book value, indicating strong market confidence.

Price to Sales Ratio (P/S)

The Healthcare Global Enterprises Ltd P/S ratio currently stands at 3.43, an important part of Healthcare Global Enterprises Ltd Ratios for revenue valuation.

Historical P/S ratio:

• 2024: 3.43
• 2023: 2.49
• 2022: 2.17
• 2021: 2.62

The rising Healthcare Global Enterprises Ltd P/S ratio indicates improved revenue valuation by investors.

Healthcare Global Enterprises Ltd Price to Cash Flow Ratio (P/CF)

The Healthcare Global Enterprises Ltd Price to Cash Flow Ratio is a key valuation metric that shows how much investors pay for each unit of cash flow. Current P/CF ratio is 30.40.

Historical Healthcare Global Enterprises Ltd Price to Cash Flow Ratio:

• 2024: 30.40
• 2023: 20.98
• 2022: 17.46
• 2021: 18.86
• 2020: 30.04

The rising Healthcare Global Enterprises Ltd Price to Cash Flow Ratio indicates premium valuation based on cash flow.

Healthcare Global Enterprises Ltd Enterprise Value Ratios

Enterprise Value (EV)

The Healthcare Global Enterprises Ltd EV currently stands at ₹91.7B, representing the total company valuation including debt.

Historical EV trend:

• 2024: 91.7B
• 2023: 57.59B
• 2022: 43.84B
• 2021: 43.73B

Healthcare Global Enterprises Ltd enterprise value shows long-term growth, reflecting expansion and market confidence.

EV/EBITDA Ratio

The Healthcare Global Enterprises Ltd EV/EBITDA ratio is currently 23.78, a key metric in Healthcare Global Enterprises Ltd Ratios to assess valuation relative to earnings.

Historical EV/EBITDA:

• 2024: 23.78
• 2023: 17.55
• 2022: 13.33
• 2021: 18.44

Higher Healthcare Global Enterprises Ltd EV/EBITDA suggests premium valuation.

Healthcare Global Enterprises Ltd Financial Strength Ratios

Debt to Equity Ratio (D/E)

The Healthcare Global Enterprises Ltd D/E ratio is currently 1.99, reflecting leverage and financial stability.

Historical D/E:

• 2024: 1.99
• 2023: 1.54
• 2022: 1.05
• 2021: 1.05

Higher D/E ratio indicates rising financial risk.

Return on Equity (ROE %)

The Healthcare Global Enterprises Ltd ROE currently stands at 5.08%, showing profitability and capital efficiency.

Historical ROE:

• 2024: 5.08
• 2023: 5.71
• 2022: 3.39
• 2021: 6.86

Declining ROE indicates pressure on profitability.

Healthcare Global Enterprises Ltd Ratios Analysis Summary

The Healthcare Global Enterprises Ltd Ratios page provides a comprehensive view of the company's valuation and financial performance. Key metrics such as P/E, P/B, P/S, P/CF, EV, EV/EBITDA, D/E, and ROE help investors understand whether Healthcare Global Enterprises Ltd stock is undervalued, fairly valued, or overvalued.

Tracking Healthcare Global Enterprises Ltd Ratios regularly helps investors make informed decisions based on valuation trends, financial stability, and long-term growth potential.